What are Incretin mimetics?
Incretin mimetics are agents that act like incretin hormones such as glucagon-like peptide-1 (GLP-1). They bind to GLP-1 receptors and stimulate glucose dependent insulin release, therefore act as antihyperglycemics.
Incretin mimetics also suppress appetite and inhibit glucagon secretion. They slow gastric emptying and as a result prevent steep rise in post-prandial blood glucose levels.
Incretin mimetics are only used to treat type 2 diabetes.
List of Incretin mimetics:
|Drug Name||Reviews||Avg. Ratings|
|albiglutide systemic (Pro)||11 reviews||4.6|
|dulaglutide systemic (Pro)||820 reviews||5.2|
|exenatide systemic (Pro)||384 reviews||6.8|
|liraglutide systemic (Pro)||2,018 reviews||7.7|
|lixisenatide systemic (Pro)||0 reviews||Add rating|
|semaglutide systemic (Pro)||429 reviews||6.3|
|For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).|
Medical conditions associated with incretin mimetics:
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.